Editor's Note

A hazardous antibiotic injection of clindamycin phosphate glucose (Chinese name "Xinfu"), produced by the Anhui Huayuan Worldbest Biology Pharmacy Co, caused six deaths, and 93 ill in the country, according to the results of an investigation by the State Food and Drug Administration (SFDA) on August 15. The first reports about problems with the injection came on July 27. Severe adverse reactions include chest, kidney or stomach pains, vomiting and anaphylactic shock. The Ministry of Health issued an urgent notice to ban use of the drug in August. A deadline of August 31 was set to recall all suspect "Xinfu" antibiotic injections. SFDA investigation said the drug was not properly sterilized according to sterilization temperature and duration set within the state standard.


· Watchdog Punishes Drug Manufacturer
· Manufacturer of Suspect Killer Antibiotic Punished
· Manufacturer of Suspect Killer Antibiotic Punished
· Antibiotic Aabuse: a Factor in Increase of Recessive Syphilis
· Deadline Set for Recall of Killer Drug
· Deadline Set for Recall of Killer Drug
· Improper Disinfection Blamed for Antibiotic-related Deaths
· Improper Disinfection Blamed for Antibiotic-related Deaths
· Production Faults Cause Antibiotic-related Deaths
· Production Faults Cause Antibiotic-related Deaths
· Improper Production of Injection Causes of Deaths
· Improper Production Causes Antibiotic-related Deaths
· Ministry Demands Daily Reports on Suspect Antibiotic
· Ministry Demands Daily Reports on Suspect Antibiotic
· Probe Drug Tragedy
· Problematic Injection Kills 3, Sickens 78
· Ex-official Gets 5 Years for Mine Blast
· Safety Official Found to Own Bloody Mine